Syngene International Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹736.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.99 per cent from ₹1,036.50 crore. This corresponds to a year-on-year *(YoY) decline of 15.84 per cent.
Operating Profit
Operating Profit stands at ₹77.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 74.01 per cent from ₹297.40 crore. This corresponds to a year-on-year *(YoY) decline of 62.55 per cent.
PBDT
PBDT stands at ₹93.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 69.76 per cent from ₹307.50 crore. This corresponds to a year-on-year *(YoY) decline of 56.24 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-19.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 109.80 per cent from ₹196.00 crore. This corresponds to a year-on-year *(YoY) decline of 118.95 per cent.
Net Profit
Net Profit stands at ₹-9.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 106.09 per cent from ₹147.90 crore. This represents a 110.38 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Syngene International Ltd Earnings
- YOY
- QOQ
Syngene International Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Syngene International Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Syngene International Ltd Financial Reports
Syngene International Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Syngene Intl. | 0.00% | -3.13% | -3.64% | -14.67% | -5.33% | -40.57% |
| Dr Lal Pathlabs | 0.36% | -0.62% | -2.27% | 21.61% | 38.68% | 18.45% |
| Poly Medicure | 1.66% | -2.19% | -2.41% | 22.12% | 34.57% | -11.59% |
| Dr Agarwal's Hea | 0.57% | 1.19% | -7.72% | 15.58% | 16.37% | 22.18% |
| Vijaya Diagnost. | 0.41% | -0.25% | 7.86% | 18.70% | 58.55% | 43.03% |
| Rainbow Child. | -1.09% | 0.55% | -5.70% | 8.20% | 22.66% | -2.61% |
| Indegene | -1.01% | -1.69% | 3.78% | 13.78% | 30.40% | 5.81% |
Company Info
Company Information
Executive Chairman : Kiran Mazumdar Shaw
Managing Director & CEO : Peter John Bains
Non-Exec & Non-Independent Dir : Catherine Patricia Rosenberg
Non-Exec & Non-Independent Dir : Vinita Bali
Independent Non Exe. Director : Kush Parmar
Lead Independent Non Executive Director : Sharmila Karve
Independent Non Exe. Director : Nilanjan Roy
Independent Non Exe. Director : Manja Boerman
Independent Non Exe. Director : Sanjaya Singh
Independent Non Exe. Director : Suresh Narayanan
Independent Director : Arun Suresh Chandavarkar
Company Sec. & Compli. Officer : Chethan Yogesh
Independent Director : Vijaya Chandru